Scientific Publications
Left Column Title:
Scientific Publications
Left Column Content:
- Health Benefits and Cost-Effectiveness of a Hybrid Screening Strategy for Colorectal Cancer
[ »Clin Gastroenterol Hepatol, Mar 2013] -
Modeling the Impact of Increased Adherence to Asthma Therapy
[ »PLOS ONE, Dec 2012] -
The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
[ »ClinicoEconomics and Outcomes Research, Nov 2012] -
The Global Outcomes Score: A Quality Measure, Based On Health Outcomes, That Compares Current Care To A Target Level Of Care
[ »Health Affairs, Nov 2012. Free full text until 6/14/2013)] -
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force
[ »Value Health, Oct 2012] -
A Simulation Shows Limited Savings From Meeting Quality Targets Under The Medicare Shared Savings Program
[ »Health Affairs, Oct 2012] -
Cost-Effectiveness Analysis of a Community Health Worker Intervention for Low-Income Hispanic Adults with Diabetes
[ »Preventing Chronic Disease, Aug 2012] -
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
[ »Vascular Health and Risk Management, Apr 2012] -
Physicians’ Actions And Influence, Such As Aggressive Blood Pressure Control, Greatly Improve The Health Of Diabetes Patients
[ »Health Affairs, Jan 2012] -
An Estrogen Model: The Relationship between Body Mass Index, Menopausal Status, Estrogen Replacement Therapy, and Breast Cancer Risk
[ »Computational and Mathematical Methods in Medicine, Jan 2012] -
Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectiveness Study in Diabetic Populations
[ »Journal of Internal General Medicine, Jan 2012] -
Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
[ »Diabetes, Obesity, and Metabolism 9/6/2011] -
Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients with Severe Hypertriglyceridemia.
[ »Am J Cardiol. 9/1/2011] -
Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs.
[ »Annals of Internal Medicine, 5/2/2011 ] -
Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population
[ »CANCER, 3/14/2011 ] -
Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population.
[ »Cancer Prevention Research, 11/18/2010 ] -
Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma.
[ »Current Medical Research and Opinion, 11/04/2010 ] -
Cost-effectiveness of adding information about common risk alleles to current decision models for breast cancer chemoprevention.
[ »Journal of Clinical Oncology, 6/07/2010 ] -
Age at Initiation and Frequency of Screening to Detect Type 2 Diabetes: A Cost-Effectiveness Analysis
[ »The Lancet, 4/30/2010 ] [ »View Technical Appendix ]
Right Column Content:
-
Model-Based Benefit-Risk Assessment: Can Archimedes Help?
[ »Clinical Pharmacology & Therapeutics, 12/15/2009 ] -
Effect of Smoking Cessation Advice on Cardiovascular Disease
[ »American Journal of Medical Quality, 5/01/2009 ] -
The Relationship between Insulin Resistance and Related Metabolic Variables to Coronary Artery Disease: A Mathematical Analysis
[ »Diabetes Care. 11/18/2008 ] -
A Physiology-Based Mathematical Model of Coronary Heart Disease Accurately Predicts CHD Event Rates in Real Populations
[ »Circulation, 11/08/2008 ] -
The potential effects of HEDIS performance measures on the quality of care
[ »Health Affairs, 9/15/2008 ] -
The Impact of Prevention on Reducing the Burden of Cardiovascular Disease
[ »Circulation, 7/29/2008 ] -
Validation of Prediction of Diabetes by Archimedes and Comparison with Other Predicting Models.
[ »Diabetes Care, 5/28/2008 ] -
The Metabolic Syndrome and Cardiovascular Risk: Implications for Clinical Practice.
[ »International Journal of Obesity, 5/1/2008 ] -
Diabetes Risk Calculator: A Simple Tool for Detecting Undiagnosed Diabetes and Prediabetes.
[ »Diabetes Care, 5/1/2008 ] -
Cure, Care, and Commitment: What Can We Look Forward To?
[ »Diabetes Care, 4/15/2008 ] -
Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy
[ »Health Affairs, 6/19/2007 ] -
Medical Decision-making: Why it must, and how it can, be improved
[ »Expert Voices, 5/15/2007 ] -
Archimedes: A Bold Step Into The Future
[ »Health Affairs, 1/26/2007 ] -
Linking Electronic Medical Records To Large-Scale Simulation Models: Can We Put Rapid Learning On Turbo?
[ »Health Affairs, 1/26/2007 ] -
Accuracy versus transparency in Pharmacoeconomic modelling: finding the right balance.
[ »Pharmacoeconomics, 6/6/2006 ] -
Bringing health economic modeling to the 21st century.
[ »Value in Health, 5/30/2006 ] -
Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
[ »Annals of Internal Medicine, 8/16/2005 ] -
Earlier intervention in type 2 diabetes: The case for achieving early.
[ »International Journal of Clinical Practice, 11/28/2005 ] -
Evidence-based medicine: a unified approach.
[ »Health Affairs, 02/15/2005 ] -
Validation of the Archimedes diabetes model.
[ »Diabetes Care, 11/15/2003 ] -
Archimedes: a trial-validated model of diabetes.
[ »Diabetes Care, 11/15/2003 ] -
Archimedes: a new model for simulating health care systems - the mathematical formulation.
[ »Journal of Biomedical Informatics, 02/06/2002
